These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522 [TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization: lessons from sickle cell disease. Treml A; King KE Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994 [No Abstract] [Full Text] [Related]
16. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Cullis JO; Win N; Dudley JM; Kaye T Vox Sang; 1995; 69(4):355-7. PubMed ID: 8751307 [TBL] [Abstract][Full Text] [Related]
17. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]
19. Delayed hemolytic transfusion reactions in sickle cell anemia. Rao KR; Patel AR South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885 [TBL] [Abstract][Full Text] [Related]
20. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Vichinsky EP Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146 [No Abstract] [Full Text] [Related] [Next] [New Search]